Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study has finished and is no longer accepting participants.
In Catonsville
This study has finished and is no longer accepting participants.
In Baltimore
Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)
This study has finished and is no longer accepting participants.
In ProvidenceEffects of Varenicline on Cortical Neuroplasticity and Working Memory in Patients With Schizophrenia and Healthy Controls
This study has finished and is no longer accepting participants.
In TorontoEvaluating the Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia: Implications for Treatment
This study has finished and is no longer accepting participants.
In TorontoEffects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals
This study has finished and is no longer accepting participants.
In BostonThis study evaluated the safety and effectiveness of Quetiapine Fumarate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Multicenter, Randomized, Parallel-Group, Double-blind, Fixed-Dose, 28-Day Trial to Assess the Efficacy and Safety of SCH 900435 Compared With Placebo, Using Olanzapine as an Active Control in Subjects With an Acute Exacerbation of Schizophrenia (GUEST - Glycine Uptake Inhibitor Efficacy and Safety Trial, Phase 2, Protocol No. P06079)
This study was withdrawn before enrollment.
Location not clearly listedThis study evaluated the safety and effectiveness of Aripiprazole for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including DownyThis study evaluated the safety and effectiveness of Paliperidone palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixThis study evaluated the safety and effectiveness of armodafinil for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.